CCI approves Carlyle Group's stake acquisition in Airtel's data centre business

On completion of the deal, Carlyle will hold about 25% stake in the business, with Airtel continuing to hold the remaining stake of about 75%.

| Updated on: Aug 20 2022, 22:41 IST
Airtel had sold 25% stake in data centre business to Carlyle for $235 million
Airtel had sold 25% stake in data centre business to Carlyle for $235 million (REUTERS)
Airtel had sold 25% stake in data centre business to Carlyle for $235 million
Airtel had sold 25% stake in data centre business to Carlyle for $235 million (REUTERS)

New Delhi, Aug 26 (PTI) The Competition Commission of India (CCI) on Wednesday said it has approved the acquisition of compulsorily convertible preference shares and equity shares in Airtel's data centre business, Nxtra Data, by Carlyle Group's Comfort Investments II.

The Carlyle Group in July said it will acquire about 25% stake in Nxtra Data Ltd for USD 235 million (about 1,780 crore).

This will peg the enterprise valuation of Nxtra Data at USD 1.2 billion, which is over 9,084 crore.

In a tweet, the regulator said it "approves proposed acquisition of compulsorily convertible preference shares & equity shares in Nxtra Data Limited @NxtraDataLtd by Comfort Investments II of Carlyle Group."

Nxtra Data is a fully-owned subsidiary of Bharti Airtel Ltd and provides data centre colocation services through its 10 data centres located in India, while Comfort Investments II is a special purpose acquisition vehicle, owned and controlled by investment funds advised by the affiliates of The Carlyle Group Inc., a combination notice filed with CCI noted.

In a separate tweet, CCI said it has approved Tau Investment Holdings Pte. Ltd's proposed acquisition of shares in JB Chemicals and Pharmaceuticals Ltd.

ALSO READ: Telecom subscriber base falls to 116.3 crore in May, Jio, BSNL gain

As per a combination notice filed with the regulator, the proposed transaction involves acquiring up to 64.90% of the total voting equity share capital of JB Chemicals by Tau Investment on a fully diluted basis by way of a share purchase agreement dated July 2, 2020, pursuant to the mandatory open offer in compliance with markets regulator Sebi's Substantial Acquisition of Shares and Takeovers norms.

JB Chemicals and Pharmaceuticals is an Indian pharmaceutical company headquartered in Mumbai, while Tau Investment is a Singapore-based firm primarily engaged in holding investments.

It is an indirect wholly-owned subsidiary of KKR Asian Fund III L.P. (Ontario), the notice said.

ALSO READ: Bharti Airtel chairman Sunil Mittal hints at mobile services rate hike

Separately, the regulator also approved Lightstone Fund S.A's acquisition of equity stake in five firms on behalf of Lightstone Global Fund.

The firms in which Lightstone Fund S.A would be picking stakes are -- Ascent Health and Wellness Solutions Pvt Ltd, Aahaan Commercials Pvt Ltd, Lokprakash Vidhya Pvt Ltd, 91Streets Media Technologies Pvt Ltd and API Holdings Pvt Ltd. 

Follow HT Tech for the latest tech news and reviews , also keep up with us on Twitter, Facebook, Google News, and Instagram. For our latest videos, subscribe to our YouTube channel.

First Published Date: 27 Aug, 09:47 IST
keep up with tech